Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob C Laister

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|March 23, 2013
Metabolic adaptation to chronic inhibition of mitochondrial protein synthesis in acute myeloid leukemia cellsBozhena Jhas, Shrivani Sriskanthadevan, Marko Skrtic, et al.
Cancers|July 29, 2023
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to ImmunotherapyMaysa Vilbert, Erica C Koch, April A N Rose, et al.
Journal of Molecular Biology|July 5, 2005
A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinantsAntonio Pineda-Lucena, Cynthia S W Ho, Daniel Y L Mao, et al.
ACS Medicinal Chemistry Letters|November 25, 2014
Nanomolar-Potency Small Molecule Inhibitor of STAT5 ProteinAbbarna A Cumaraswamy, Andrew M Lewis, Mulu Geletu, et al.
Nature Communications|October 25, 2017
Evolution of AF6-RAS association and its implications in mixed-lineage leukemiaMatthew J Smith, Elizabeth Ottoni, Noboru Ishiyama, et al.
Critical Reviews in Oncology/Hematology|September 24, 2022
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping reviewKate R Oppegaard, Terri S Armstrong, Joaquin A Anguera, et al.
Leukemia|August 8, 2024
GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphomaMichael Y He, Kit I Tong, Ting Liu, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Biomaterials|April 19, 2023
Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogelsLaura C Bahlmann, Chang Xue, Allysia A Chin, et al.
Cell Reports. Medicine|March 9, 2024
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapyMichael St Paul, Samuel D Saibil, Meghan Kates, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|March 23, 2013
Metabolic adaptation to chronic inhibition of mitochondrial protein synthesis in acute myeloid leukemia cellsBozhena Jhas, Shrivani Sriskanthadevan, Marko Skrtic, et al.
Cancers|July 29, 2023
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to ImmunotherapyMaysa Vilbert, Erica C Koch, April A N Rose, et al.
Journal of Molecular Biology|July 5, 2005
A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinantsAntonio Pineda-Lucena, Cynthia S W Ho, Daniel Y L Mao, et al.
ACS Medicinal Chemistry Letters|November 25, 2014
Nanomolar-Potency Small Molecule Inhibitor of STAT5 ProteinAbbarna A Cumaraswamy, Andrew M Lewis, Mulu Geletu, et al.
Nature Communications|October 25, 2017
Evolution of AF6-RAS association and its implications in mixed-lineage leukemiaMatthew J Smith, Elizabeth Ottoni, Noboru Ishiyama, et al.
Critical Reviews in Oncology/Hematology|September 24, 2022
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping reviewKate R Oppegaard, Terri S Armstrong, Joaquin A Anguera, et al.
Leukemia|August 8, 2024
GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphomaMichael Y He, Kit I Tong, Ting Liu, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Biomaterials|April 19, 2023
Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogelsLaura C Bahlmann, Chang Xue, Allysia A Chin, et al.
Cell Reports. Medicine|March 9, 2024
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapyMichael St Paul, Samuel D Saibil, Meghan Kates, et al.
Pageof 3